Top

Published in:

01-11-2017 | Original Article

Novel insights into a reputably irreversible process: combined mRNA and miRNA profiling of tissue from vesicourethral anastomotic stenosis after radical prostatectomy

Authors: T. S. Worst, K. Daskalova, A. Steidler, K. Berner-Leischner, R. Röth, B. Niesler, C.-A. Weis, M. C. Kriegmair, P. Erben, D. Pfalzgraf

Published in: World Journal of Urology | Issue 11/2017

Abstract

Purpose

Until recently, tissue fibrosis—ultimately leading to permanent scaring—has been considered an irreversible process. However, recent findings indicate that it may be reversible after all. Vesicourethral anastomotic stenosis (VUAS) as fibrous narrowing is a frequent complication after radical prostatectomy with high recurrence rates and requires invasive treatment. The pathophysiology is poorly understood. Therefore, a combined mRNA and miRNA transcription profiling in tissue from VUAS was performed using nCounter technology.

Methods

To assess tissue morphology and fiber composition, histochemical staining was performed. RNA expression of healthy and fibrotic tissue of twelve patients was analyzed using the human miRNA panel v3 and mRNA PanCancer pathway panel on the nCounter gene1 system and qRT-PCR. Differential expression data analysis was performed using the nSolver software implementing the R-based advanced pathway analysis tool. miRWalk2.0 was used for miRNA target prediction.

Results

More linearized tissue architecture, increased collagens, and decreased elastic fibers were observed in VUAS samples. 23 miRNAs and 118 protein coding genes were differentially expressed (p < 0.01) in fibrotic tissue. miRNA target prediction and overlap analysis indicated an interaction of the strongest deregulated miRNAs with 29 deregulated mRNAs. Pathway analysis revealed alterations in DNA repair, cell cycle regulation, and TGF-beta signaling. qRT-PCR confirmed differential expression of top deregulated miRNAs and mRNAs.

Conclusions

In VUAS tissue, severe alterations on mRNA and miRNA level are found. These consistent changes give insights into the pathogenesis of VUAS after radical prostatectomy and point to future options for transcriptomics-based risk stratification and targeted therapies.

Available only for authorised users

Hammel P, Couvelard A, O’Toole D et al (2001) Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 344:418–423. doi:10.1056/NEJM200102083440604 CrossRefPubMed

Ding N, Hah N, Yu RT et al (2015) BRD4 is a novel therapeutic target for liver fibrosis. Proc Natl Acad Sci USA 112:15713–15718. doi:10.1073/pnas.1522163112 PubMedPubMedCentral

Zou X-Z, Liu T, Gong Z-C et al (2017) MicroRNAs-mediated epithelial–mesenchymal transition in fibrotic diseases. Eur J Pharmacol 796:190–206. doi:10.1016/j.ejphar.2016.12.003 CrossRefPubMed

Ghosh AK, Rai R, Flevaris P, Vaughan DE (2016) Epigenetics in reactive and reparative cardiac fibrogenesis: the promise of epigenetic therapy. J Cell Physiol. doi:10.1002/jcp.25699 PubMed

Breyer BN, Davis CB, Cowan JE et al (2010) Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU Int 106:1734–1738. doi:10.1111/j.1464-410X.2010.09333.x CrossRefPubMedPubMedCentral

Centers for Disease Control and Prevention (2016) Fast stats on prostatectomy procedures. http://www.cdc.gov/nchs/fastats/prostate.htm. Accessed 24 Oct 2016

Krishna CV, Singh J, Thangavel C, Rattan S (2016) Role of microRNAs in gastrointestinal smooth muscle fibrosis and dysfunction: novel molecular perspectives on the pathophysiology and therapeutic targeting. Am J Physiol Gastrointest Liver Physiol 310:G449–G459. doi:10.1152/ajpgi.00445.2015 CrossRefPubMedPubMedCentral

Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233. doi:10.1016/j.cell.2009.01.002 CrossRefPubMedPubMedCentral

Kashiyama K, Mitsutake N, Matsuse M et al (2012) miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts. J Invest Dermatol 132:1597–1604. doi:10.1038/jid.2012.22 CrossRefPubMed

10.

Sundaram GM, Common JEA, Gopal FE et al (2013) “See-saw” expression of microRNA-198 and FSTL1 from a single transcript in wound healing. Nature 495:103–106. doi:10.1038/nature11890 CrossRefPubMed

11.

Etoh M, Jinnin M, Makino K et al (2013) microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma. Arch Dermatol Res 305:9–15. doi:10.1007/s00403-012-1287-4 CrossRefPubMed

12.

Ning P, Liu D, Mao Y et al (2012) Differential expression profile of microRNA between hyperplastic scar and normal skin. Zhonghua Yi Xue Za Zhi 92:692–694PubMed

13.

Gregory PA, Bert AG, Paterson EL et al (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10:593–601. doi:10.1038/ncb1722 CrossRefPubMed

14.

Huang Y, Tong J, He F et al (2015) miR-141 regulates TGF-β1-induced epithelial-mesenchymal transition through repression of HIPK2 expression in renal tubular epithelial cells. Int J Mol Med 35:311–318. doi:10.3892/ijmm.2014.2008 CrossRefPubMed

15.

Cisternas P, Vio CP, Inestrosa NC (2014) Role of Wnt signaling in tissue fibrosis, lessons from skeletal muscle and kidney. Curr Mol Med 14:510–522CrossRefPubMed

16.

Sato M (2006) Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids. Acta Derm Venereol 86:300–307. doi:10.2340/00015555-0101 CrossRefPubMed

17.

Liu Z, Yi J, Ye R et al (2015) miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver. Int J Clin Exp Pathol 8:3994–4000PubMedPubMedCentral

18.

Xu Z, Ramachandran S, Gunasekaran M et al (2015) MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation. J Heart Lung Transplant Off Publ Int Soc Heart Transplant 34:1154–1162. doi:10.1016/j.healun.2015.03.021 CrossRef

19.

Ostendorf T, Boor P, van Roeyen CRC, Floege J (2014) Platelet-derived growth factors (PDGFs) in glomerular and tubulointerstitial fibrosis. Kidney Int Suppl 4:65–69. doi:10.1038/kisup.2014.12 CrossRef

20.

Shah R, Reyes-Gordillo K, Arellanes-Robledo J et al (2013) TGF-β1 up-regulates the expression of PDGF-β receptor mRNA and induces a delayed PI3K-, AKT-, and p70(S6K) -dependent proliferative response in activated hepatic stellate cells. Alcohol Clin Exp Res 37:1838–1848. doi:10.1111/acer.12167 CrossRefPubMed

21.

Kim W, Barron DA, San Martin R et al (2014) RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation. Proc Natl Acad Sci USA 111:16389–16394. doi:10.1073/pnas.1407097111 CrossRefPubMedPubMedCentral

22.

Adrados I, Larrasa-Alonso J, Galarreta A et al (2016) The homeoprotein SIX1 controls cellular senescence through the regulation of p16INK4A and differentiation-related genes. Oncogene 35:3485–3494. doi:10.1038/onc.2015.408 CrossRefPubMed

23.

Meyer K, Hodwin B, Ramanujam D et al (2016) Essential role for premature senescence of myofibroblasts in myocardial fibrosis. J Am Coll Cardiol 67:2018–2028. doi:10.1016/j.jacc.2016.02.047 CrossRefPubMed

24.

Jumper N, Paus R, Bayat A (2015) Functional histopathology of keloid disease. Histol Histopathol 30:1033–1057. doi:10.14670/HH-11-624 PubMed

25.

Schulz J-N, Nüchel J, Niehoff A et al (2016) COMP-assisted collagen secretion—a novel intracellular function required for fibrosis. J Cell Sci 129:706–716. doi:10.1242/jcs.180216 CrossRefPubMed

26.

Marfella R, Di Filippo C, Potenza N et al (2013) Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders. Eur J Heart Fail 15:1277–1288. doi:10.1093/eurjhf/hft088 CrossRefPubMed

27.

Makiguchi T, Yamada M, Yoshioka Y et al (2016) Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis. Respir Res 17:110. doi:10.1186/s12931-016-0427-3 CrossRefPubMedPubMedCentral

28.

Biglino G, Caputo M, Rajakaruna C et al (2017) Modulating microRNAs in cardiac surgery patients: novel therapeutic opportunities? Pharmacol Ther 170:192–204. doi:10.1016/j.pharmthera.2016.11.004 CrossRefPubMed

29.

Bouchie A (2013) First microRNA mimic enters clinic. Nat Biotechnol 31:577. doi:10.1038/nbt0713-577 CrossRefPubMed

30.

van der Ree MH, van der Meer AJ, de Bruijne J et al (2014) Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients. Antiviral Res 111:53–59. doi:10.1016/j.antiviral.2014.08.015 CrossRefPubMed

31.

Zhang K, Guo X, Zhao W et al (2015) Application of Wnt pathway inhibitor delivering scaffold for inhibiting fibrosis in urethra strictures. In vitro and in vivo study. Int J Mol Sci 16:27659–27676. doi:10.3390/ijms161126050 CrossRefPubMedPubMedCentral

Title: Novel insights into a reputably irreversible process: combined mRNA and miRNA profiling of tissue from vesicourethral anastomotic stenosis after radical prostatectomy
Authors: T. S. Worst
K. Daskalova
A. Steidler
K. Berner-Leischner
R. Röth
B. Niesler
C.-A. Weis
M. C. Kriegmair
P. Erben
D. Pfalzgraf
Publication date: 01-11-2017
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 11/2017
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-017-2060-2

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Novel insights into a reputably irreversible process: combined mRNA and miRNA profiling of tissue from vesicourethral anastomotic stenosis after radical prostatectomy

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2017

The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis

Review on diagnosis and management of urolithiasis in pregnancy: an ESUT practical guide for urologists

Population-based study of grade progression in patients who harboured Gleason 3 + 3

Laparoscopic vesico-ureteral reimplantation with Lich–Gregoir approach in children: medium term results of 159 renal units in 117 children

“Finding the needle in a haystack”: oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP)

Outcome from 5-year live surgical demonstrations in urinary stone treatment: are outcomes compromised?